Immune Response to Extracellular Matrix Collagen in Chronic Hepatitis C-Induced Liver Fibrosis

被引:16
作者
Borg, Brian B. [2 ]
Seetharam, Anil [2 ]
Subramanian, Vijay [1 ]
Basha, Haseeb Ilias [1 ]
Lisker-Melman, Mauricio [2 ]
Korenblat, Kevin [2 ]
Anderson, Christopher D. [1 ]
Shenoy, Surendra [1 ]
Chapman, William C. [1 ]
Crippin, Jeffrey S. [2 ]
Mohanakumar, Thalachallour [1 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
NATURAL-HISTORY; VIRUS-INFECTION; ALLOGRAFT-REJECTION; V COLLAGEN; ANTIBODIES; TRANSPLANTATION; AUTOANTIBODIES; RECURRENT; DISEASE; CELLS;
D O I
10.1002/lt.22303
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) infection and its recurrence after orthotopic liver transplantation (OLT) are associated with the remodeling of extracellular matrix (ECM) components [ particularly collagen (Col)], which leads to fibrosis. Our aim was to determine whether the development of antibodies (Abs) to self-antigen Col in HCV-infected patients correlates with the fibrosis stage and the peripheral cytokine response. Patients with chronic HCV infection, patients with HCV recurrence after OLT who had undergone a biopsy procedure, and healthy control subjects were enrolled. The HCV subjects (n = 70) were stratified as follows: (1) a non-OLT group without fibrosis (Scheuer stages 0-2), (2) a non-OLT group with fibrosis (Scheuer stages 3-4), (3) a post-OLT group without fibrosis (Scheuer stages 0-2), and (4) a post-OLT group with fibrosis (Scheuer stages 3-4). Serum samples were analyzed for Abs against Col1, Col2, Col4, Col5, and vimentin with enzyme-linked immunosorbent assays. Serum levels of cytokines were measured with multiplex bead immunoassays. The levels of Abs to Col1 were higher in the fibrosis groups versus the no-fibrosis groups and the controls for both non-OLT patients (P < 0.001) and post-OLT patients (P = 0.01). There were increased levels of Abs to Col2, Col4, Col5, and vimentin in the non-OLT fibrosis group (Col2, P = 0.0001; Col4, P = 0.122; Col5, P < 0.0001; vimentin, P = 0.36) and in the post-OLT fibrosis group (Col2, P = 0.006; Col4, P = 0.19; Col5, P < 0.0001; vimentin, P = 0.24) in comparison with the no-fibrosis groups. The non-OLT and post-OLT fibrosis groups demonstrated significantly higher T helper 2 (T(h)2) and T helper 17 (T(h)17) cytokine levels and lower T helper 1 cytokine levels in comparison with the no-fibrosis groups. Our results demonstrate that in HCV-infected patients, the levels of Abs to ECM Col1, Col2, and Col5 positively correlate with liver fibrosis, which is associated with a predominantly Th2 and Th17 cytokine profile. Liver Transpl 17:814-823, 2011. (C) 2011 AASLD.
引用
收藏
页码:814 / 823
页数:10
相关论文
共 46 条
[1]   Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia [J].
Antonelli, Alessandro ;
Ferri, Clodoveo ;
Ferrari, Silvia Martina ;
Colaci, Michele ;
Fallahi, Poupak .
AUTOIMMUNITY REVIEWS, 2008, 8 (01) :18-23
[2]   Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China [J].
Bai Li ;
Feng Zhen-ru ;
Lu Hai-ying ;
Li Wen-gang ;
Yu Min ;
Xu Xiao-yuan .
CHINESE MEDICAL JOURNAL, 2009, 122 (01) :5-9
[3]   Characterization of HCV-Specific CD4+Th17 Immunity in Recurrent Hepatitis C-Induced Liver Allograft Fibrosis [J].
Basha, H. I. ;
Subramanian, V. ;
Seetharam, A. ;
Nath, D. S. ;
Ramachandran, S. ;
Anderson, C. D. ;
Shenoy, S. ;
Chapman, W. C. ;
Crippin, J. S. ;
Mohanakumar, T. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (04) :775-785
[4]   CHRONIC HEPATITIS - AN UPDATE ON TERMINOLOGY AND REPORTING [J].
BATTS, KP ;
LUDWIG, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (12) :1409-1417
[5]   Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis [J].
Bharat, A. ;
Barros, F. ;
Narayanan, K. ;
Borg, B. ;
Lisker-Melman, M. ;
Shenoy, S. ;
Lowell, J. ;
Crippin, J. ;
Chapman, W. ;
Mohanakumar, T. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (06) :1214-1220
[6]   Antibodies to Self-Antigens Predispose to Primary Lung Allograft Dysfunction and Chronic Rejection [J].
Bharat, Ankit ;
Saini, Deepti ;
Steward, Nancy ;
Hachem, Ramsey ;
Trulock, Elbert P. ;
Patterson, Alexander ;
Meyers, Bryan F. ;
Mohanakumar, Thalachallour .
ANNALS OF THORACIC SURGERY, 2010, 90 (04) :1094-1100
[7]   B cells: no longer bystanders no liver fibroses [J].
Bhogal, RK ;
Bona, CA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :2962-2965
[8]   Fas/FasL system, IL-1β expression and apoptosis in chronic HBV and HCV liver disease [J].
Bortolami, M. ;
Kotsafti, A. ;
Cardin, R. ;
Farinati, F. .
JOURNAL OF VIRAL HEPATITIS, 2008, 15 (07) :515-522
[9]   Hepatitis C-Associated Rheumatic Disorders [J].
Buskila, Dan .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2009, 35 (01) :111-+
[10]   Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses [J].
Caldas, C. ;
Luna, E. ;
Spadafora-Ferreira, M. ;
Porto, G. ;
Iwai, L. K. ;
Oshiro, S. E. ;
Monteiro, S. M. ;
Fonseca, J. A. ;
Lemos, F. ;
Hammer, J. ;
Ho, P. L. ;
Kalil, J. ;
Coelho, V. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (01) :66-75